Biohaven Statistics Share Statistics Biohaven has 105.79M
shares outstanding. The number of shares has increased by 4.62%
in one year.
Shares Outstanding 105.79M Shares Change (YoY) 4.62% Shares Change (QoQ) 3.6% Owned by Institutions (%) 82.23% Shares Floating 88.38M Failed to Deliver (FTD) Shares 69 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 13.19M, so 12.47% of the outstanding
shares have been sold short.
Short Interest 13.19M Short % of Shares Out 12.47% Short % of Float 14.02% Short Ratio (days to cover) 6.09
Valuation Ratios The PE ratio is -4.03 and the forward
PE ratio is -2.6.
Biohaven's PEG ratio is
-0.06.
PE Ratio -4.03 Forward PE -2.6 PS Ratio 0 Forward PS 15.4 PB Ratio 8.05 P/FCF Ratio -5.81 PEG Ratio -0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Biohaven.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.49,
with a Debt / Equity ratio of 0.09.
Current Ratio 3.49 Quick Ratio 3.49 Debt / Equity 0.09 Debt / EBITDA -0.04 Debt / FCF -0.06 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.31M Employee Count 256 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 735K Effective Tax Rate -0.09%
Stock Price Statistics The stock price has increased by -66.81% in the
last 52 weeks. The beta is 3.45, so Biohaven's
price volatility has been higher than the market average.
Beta 3.45 52-Week Price Change -66.81% 50-Day Moving Average 14.77 200-Day Moving Average 23.02 Relative Strength Index (RSI) 57.88 Average Volume (20 Days) 2,561,696
Income Statement
Revenue n/a Gross Profit -3.92M Operating Income -885.11M Net Income -846.42M EBITDA -841.76M EBIT -845.69M Earnings Per Share (EPS) -9.28
Full Income Statement Balance Sheet The company has 99.13M in cash and 36.58M in
debt, giving a net cash position of 62.55M.
Cash & Cash Equivalents 99.13M Total Debt 36.58M Net Cash 62.55M Retained Earnings -1.35B Total Assets 550.41M Working Capital 350.5M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -582.45M
and capital expenditures -4.05M, giving a free cash flow of -586.5M.
Operating Cash Flow -582.45M Capital Expenditures -4.05M Free Cash Flow -586.5M FCF Per Share -6.43
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
